A $2.3M grant from Australian Cancer Research Foundation (ACRF) is being awarded to The University of Queensland’s Institute for Molecular Bioscience (IMB) today to establish the new ACRF Cancer Ultrastructure and Function Facility (CUFF).
The nation-leading facility will provide cutting-edge imaging capabilities for tracking and visualising cancer. Researchers will be able to see cancer cells grow, spread and respond to drugs in real time. This will help them learn how cancer cells behave and change, and ultimately, develop new treatments to control cancer.
“The need for this facility came from a realisation that we are at a crucial juncture in global cancer research. Despite outstanding developments in understanding the genetic changes in cancer, we still do not understand how these changes cause cancers to grow and spread,” says Professor Brandon Wainwright, Director, IMB.
The researchers at IMB are hopeful that the revolutionary new advances in microscopy will provide the opportunity to break this roadblock.
“Donations received by ACRF help to provide researchers with the most powerful tools available. The three new microscopes at IMB will allow researchers to observe the structure and function of living cancer cells in real time with unprecedented resolution, giving them the opportunity to optimally target and fine-tune cancer treatments. It is our hope that they will assist IMB in making significant contributions to the global understanding of how cancers grow and develop to improve treatments and patient outcomes,” says Professor Ian Brown, CEO of the Australian Cancer Research Foundation.
The new ACRF Cancer Ultrastructure and Function Facility represents an apex of multidisciplinary efforts. Biologists, physicians and chemists will work together to build a deeper understanding of cancer biology and pioneer new therapeutic approaches to beat the disease.
ACRF has supported cancer research at The University of Queensland’s Institute for Molecular Bioscience since 1994. Over the past 22 years, ACRF has awarded three grants totalling $4.8M to the institute for research into all types of cancer.
“ACRF is proud to continue to support the cutting-edge research being carried out at IMB. It is our mission to do everything we can to provide Australia’s best researchers with the tools they need to end cancer,” concludes Professor Brown.
Related Posts